Chief Executive Officer
F
Ferryx
The startup develops live biotherapeutics using safe bacterial products to treat gastrointestinal inflammation, including inflammatory bowel disease and irritable bowel syndrome, in both humans and animals. By providing natural alternatives to traditional medications, the company aims to reduce the negative side effects associated with conventional treatments.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$330KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops live biotherapeutics using safe bacterial products to treat gastrointestinal inflammation, including inflammatory bowel disease and irritable bowel syndrome, in both humans and animals. By providing natural alternatives to traditional medications, the company aims to reduce the negative side effects associated with conventional treatments.